US FDA Panel Says More Study on Human Genome Sciences, Inc. (JOBS) Anthrax Drug

SILVER SPRING, Md., Oct 27 (Reuters) - Animal data suggests a proposed Human Genome Sciences Inc (HGSI.O) drug may help people exposed to anthrax but more study is needed to show the treatment adds benefit beyond antibiotics alone, a U.S. advisory panel said on Tuesday.

Back to news